Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003468049 | SCV004193543 | likely pathogenic | Retinitis pigmentosa 25 | 2023-01-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003679217 | SCV004402848 | pathogenic | not provided | 2023-10-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr1949Thrfs*38) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EYS-related conditions. For these reasons, this variant has been classified as Pathogenic. |